Plain-English translation of NCT05313191 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing pencil beam scanning proton therapy for patients whose cancer has returned or a new tumor has developed after previous radiation treatment. Proton therapy is a highly targeted form of radiation that delivers energy more precisely to the tumor while sparing healthy tissues around it. Researchers want to see if this treatment can safely deliver stronger doses to fight recurrent cancers better than traditional approaches used today.
When cancer returns after radiation therapy, doctors face a difficult choice: use lower radiation doses to avoid harming healthy tissue (which may not be strong enough to kill the cancer), or treat a smaller area than ideal. This treatment offers a potentially better option by delivering radiation more precisely to the tumor while protecting surrounding healthy tissue.
You likely qualify if…
You likely don't qualify if…
You will receive proton therapy as your cancer treatment. The trial involves different treatment schedules and doses depending on your type of cancer and where it is located. You will have a medical exam and provide informed consent before starting. You will then undergo the proton therapy treatment course, with follow-up visits and monitoring to track how well the treatment works and any side effects you may experience.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States